Results 11 to 20 of about 6,831 (145)

Reversible synaptic deficits in early-stage batten disease [PDF]

open access: yesJournal of Translational Medicine
Background Juvenile neuronal ceroid lipofuscinosis (JNCL, Batten Disease) is a childhood-onset, neurodegenerative, lysosomal storage disorder caused by mutations in the lysosomal gene CLN3. Progressive cognitive decline is characteristic clinical feature,
Masood Ahmad Wani   +4 more
doaj   +2 more sources

Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease) [PDF]

open access: yesFrontiers in Cell and Developmental Biology, 2022
The neuronal ceroid lipofuscinoses (NCLs), also referred to as Batten disease, are a family of neurodegenerative diseases that affect all age groups and ethnicities around the globe. At least a dozen NCL subtypes have been identified that are each linked
William D. Kim   +7 more
doaj   +2 more sources

Modeling CLN3 Batten disease in astrocytes reveals alterations in mitochondria homeostasis, fatty acid metabolism and oxidative stress response [PDF]

open access: yesJournal of Biomedical Science
Background CLN3 Batten disease is a severe pediatric neurodegenerative disorder caused by mutations in the CLN3 gene, most commonly a 1 kb deletion encompassing exons 7 and 8.
Mingyi Yang   +12 more
doaj   +2 more sources

Deficiency of the Lysosomal Protein CLN5 Alters Lysosomal Function and Movement

open access: yesBiomolecules, 2021
Batten disease is a devastating, childhood, rare neurodegenerative disease characterised by the rapid deterioration of cognition and movement, leading to death within ten to thirty years of age.
Indranil Basak   +3 more
doaj   +1 more source

Impact of the COVID-19 pandemic on access to the cerliponase alfa managed access agreement in England for CLN2 treatment

open access: yesOrphanet Journal of Rare Diseases, 2022
Background Cerliponase alfa, an enzyme replacement therapy for neuronal ceroid lipofuscinosis type 2 (CLN2), is currently available in England through a managed access agreement (MAA).
Amanda Mortensen   +2 more
doaj   +1 more source

Bilateral visual loss, behavioral changes, and overlooking in a young child with stargardt disease: Neurodiagnostic considerations

open access: yesAmerican Journal of Ophthalmology Case Reports, 2022
Purpose: To illustrate the potential diagnostic confusion between Batten disease and Stargardt disease created by associated signs and symptoms. Observations: A six-year-old girl with vision loss and prominent behavioral changes and overlooking was ...
Michael C. Brodsky, Arlene Drack
doaj   +1 more source

Cellular models of Batten disease.

open access: yesBiochim Biophys Acta Mol Basis Dis, 2020
The Neuronal Ceroid Lipofuscinoses (NCL), otherwise known as Batten disease, are a group of neurodegenerative diseases caused by mutations in 13 known genes. All except one NCL is autosomal recessive in inheritance, with similar aetiology and characterised by the accumulation of autofluorescent storage material in the lysosomes of cells.
Minnis CJ   +3 more
europepmc   +4 more sources

Batten disease: an expert update on agents in preclinical and clinical trials. [PDF]

open access: yesExpert Opin Investig Drugs, 2020
Masten MC, Mink JW, Augustine EF.
europepmc   +2 more sources

A Novel Retinal Gene Therapy Strategy for Batten Disease and Beyond

open access: yesProceedings, 2020
Batten Disease is a fatal lysosomal storage disorder characterized by cognitive and [...]
Maura Schwartz   +7 more
doaj   +1 more source

Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease mice

open access: yesMolecular Therapy: Methods & Clinical Development, 2021
Batten disease is a family of rare, fatal, neuropediatric diseases presenting with memory/learning decline, blindness, and loss of motor function. Recently, we reported the use of an AAV9-mediated gene therapy that prevents disease progression in a mouse
Katherine A. White   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy